SoVote

Decentralized Democracy

House Hansard - 197

44th Parl. 1st Sess.
May 15, 2023 11:00AM
Context: House Hansard - 197 - May/15/23
Mr. Garnett Genuis (Sherwood Park—Fort Saskatchewan, CPC)
  • May/15/23 4:32:35 p.m.
  • Watch
Mr. Speaker, the next petition that I am tabling expresses the opinion of petitioners that strong medical evidence exists that access to psychedelic-assisted therapy can effectively treat existential suffering in dying, depression, anxiety, addiction, PTSD and other mental health conditions and improve quality of life. The petitioners believe that psilocybin required for psilocybin-assisted therapy is currently only available in clinical trials and by special individual permission from Health Canada, despite its low potential for harm. Further, the petitioners argue that it is paradoxical and unethical to allow MAID in these cases while preventing the same physicians from using this kind of psychedelic-assisted therapy for those in this situation. The petitioners call on the government to allow Canadians to have timely, unrestricted access to therapeutic psilocybin in any form, as needed, to alleviate their suffering via section 56 exemptions.
141 words
  • Hear!
  • Rabble!
  • star_border